Actually reached $5.60 for intra day high. As I keep saying fundamentals haven’t changed since those highs, if anything BD1 has kicked more goals. Market has become impatient and wants to see revenue and updates relating to SubB2M.
Every person’s investing strategy is different, but personally for me, this is a hold and accumulate. Bard1 have multiple products that all have potential for huge revenue when they eventually go commercial. Every announcement BD1 has released relating to their product line has reduced the risk to my investment, and until this changes I will continue to accumulate when I can.
Ann: Outstanding SubB2M Ovarian Cancer Test Data, page-533
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.0¢ |
Change
-0.035(5.60%) |
Mkt cap ! $61.72M | |||
| Open | High | Low | Value | Volume |
| 62.0¢ | 62.0¢ | 58.0¢ | $23.11K | 38.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 10009 | 58.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.0¢ | 992 | 2 |
View Market Depth
| Last trade - 14.37pm 08/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |